SciSparc Ltd. has completed the acquisition of an intellectual property portfolio from Xylo Technologies Ltd., including patents, trademarks, and know-how related to the MUSE™ system—an innovative endoscopic device for minimally invasive treatment of GERD. SciSparc plans to commercialize these technologies globally, building on Xylo’s previous licensing success in Greater China and targeting new partnerships in North America, Europe, and Latin America.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scisparc Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9642404-en) on January 26, 2026, and is solely responsible for the information contained therein.
Comments